Table 3.
Details on molecular diagnostic tools-based detection tests used for SARS-CoV-2. The details such as test name, type of test, source of sample, targeted genes, results, test time and name of the organization with their country are included
| Test Name | Type of test | Sample source | Targeted genes | Test time | Organization Name | Country |
|---|---|---|---|---|---|---|
|
iAMP COVID-19 detection Kit |
RT-RPA | Nasal, nasopharyngeal and throat swabs | ORF1 and N | <1.5 hours | Atila Biosystems Ltd. | United States |
| ID NOW COVID-19 | RT-RPA | Nasal, nasopharyngea, and throat swabs | RdRP | <5 minutes | Abbott Diagnostics Scarborough Ltd. |
United States |
| SARS-CoV-2 | RT-PCR | Nasal, nasopharyngeal, throat swabs, midturbinate nasal swabs and bronchoalveolar lavage fluid | N1 and RdRP | <1 hour | Diagnostic Molecular Laboratory |
United States |
| RT-PCR (COVID-19) | qRT-PCR | Nasal, nasopharyngeal, throat swabs, midturbinate nasal swabs, bronchoalveolar lavage fluid, aspirates, and sputum | N | 4 days | LabCorp Laboratory Corporation of America |
United States |
| ARIES SARS-CoV-2 assay | qRT-PCR | Nasal | ORF1 lab and N | 2 hours | Luminex Corporation |
United States |
| SARS-CoV-2 | RT-RPA | Respiratory samples | E and N | 30–40 minutes | Mammoth Biosciences |
United States |
| Accula SARS-CoV-2 | PCR | Throat and nasal swabs | N | 30 minutes | Mesa Biotech Inc. |
United States |
| QIAstat-Dx Respiratory SARS-CoV-2 | qRT-PCR | Nasopharyngeal | Viral RNA | 1 hour | Qiagen GmBH | United States |
| TaqPath COVID-19 combo Kit | qRT-PCR | Oropharyngeal, nasopharyngeal, and anterior nasal | ORF1, S, and N | - | Rutgers Clinical Genomics Laboratory |
United States |
| cobas SARS-CoV-2 | qRT-PCR | Nasal and nasopharyngeal | Viral RNA | 5 hours | Roche Molecular Systems. Ltd | United States |
| Viracor SARS-CoV-2 assay | qRT-PCR | Oropharyngeal, nasopharyngeal, and anterior nasal | N | 18 hours | Viracor Eurofins Clinical Diagnostics |
United States |
| BioFire COVID-19 | qRT-PCR | Nasopharyngeal | ORF1ab and ORF8 | 1. 5 hours | bioFire Defense LLC. |
United States |
| CDC-2019 | PCR | Oropharyngeal, Nasopharyngeal, and anterior nasal, nasal swabs, bronchoalveolar lavage fluid, aspirates and sputum | N | - | CDC-US | United States |
| Xepert Xpress SARS-CoV-2 | PCR | Nasal and nasopharyngeal | N2 and E | 45 Minutes | Cepheid | Australia, Canada, Singapore, and United States |
| Panther Fushion SARS-CoV-2 | PCR | Nasopharyngeal | ORF1 lab 1 and 2 | <3 hours | Hologic Inc. | Australia and United States |
|
MiRXES FORTITUDE KIT |
qRT-PCR | Nasopharyngeal | Viral RNA | 90 Minutes | mIREXES Pte Ltd. |
Singapore |
|
VitaPCR SARS-CoV-2 |
PCR | Nasal and nasopharyngeal | Viral RNA | 20 Minutes | Credo Diagnostics Biomedical Ptd. Ltd. |
Singapore |
|
Lyra SARS-CoV-2 |
qRT-PCR | Oropharyngeal and nasopharyngeal | Pp1ab | 75 Minutes | Diagnostics Hybrid Inc. |
Canada |
| Nucleic Acid Diagnostic Kit (COVID-19) | qRT-PCR | Oropharyngeal, nasopharyngeal, serum, blood, and fecus | ORF1 lab 1 and E | 30 Minutes | Sansure Biotech Inc. |
China |
|
Standard M nCOV RT Detection Kit |
qRT-PCR | Oropharyngeal swabs | E and RrRP1 | 50 Minutes | SD Biosensor |
South Korea |
RT-RPA, reverse transcription-recombinase-polymerase isothermal amplification; qRT-PCR, quantitative reverse transcriptase-polymerase chain reaction; N, nucleocapsid; ORF1, open reading frame; E, envelope; pp1ab, poly proteins.